Clinical Trials Logo

Filter by:
NCT ID: NCT03444844 Active, not recruiting - Prostate Cancer Clinical Trials

Biodistribution and Dosimetry of Ga-68 P16-093 in Prostate Cancer

Start date: May 10, 2018
Phase: Phase 1/Phase 2
Study type: Interventional

Initial performance of Ga-68-P16-093 in prostate cancer patients including dosimetry and preliminary efficacy evaluation in BCR patients, and correlation of Ga-68-P16-093 uptake with tissue histopathology in intermediate to high risk primary prostate cancer patients.

NCT ID: NCT03442569 Active, not recruiting - Colon Cancer Clinical Trials

PhII Trial Panitumumab, Nivolumab, Ipilimumab in Kras/Nras/BRAF Wild-type MSS Refractory mCRC

Start date: March 9, 2018
Phase: Phase 2
Study type: Interventional

To investigate the combination of nivolumab and ipilimumab with panitumumab in subjects with unresectable, refractory, KRAS/NRAS/BRAF wild-type, microsatellite stable (MSS) metastatic colorectal cancer.

NCT ID: NCT03442556 Active, not recruiting - Clinical trials for Castration-Resistant Prostate Carcinoma

Docetaxel, Carboplatin, and Rucaparib Camsylate in Treating Patients With Metastatic Castration Resistant Prostate Cancer With Homologous Recombination DNA Repair Deficiency

Start date: August 24, 2018
Phase: Phase 2
Study type: Interventional

This phase II trial studies how well docetaxel with carboplatin followed by rucaparib camsylate works in treating patients with metastatic castration resistant prostate cancer (spread outside of prostate and resistant to testosterone suppression) with homologous recombination DNA repair deficiency. Chemotherapy drugs, such as docetaxel and carboplatin, work to stop the growth of cancer cells, by stopping them from dividing or spreading. Rucaparib camsylate may stop the growth of tumor cells with defects in the ability to repair mistakes in DNA by forcing additional errors so that the cancer cells cannot overcome the number of errors and will then die. Giving induction docetaxel and carboplatin followed by maintenance rucaparib camsylate may work better in treating patients with castration resistant prostate cancer.

NCT ID: NCT03442413 Active, not recruiting - Smoking, Tobacco Clinical Trials

Nicotinic Hepatic Metabolism on Neuroreceptor Substrates of Nicotine Addiction

Start date: June 28, 2018
Phase: Phase 1
Study type: Interventional

Physically healthy adult smokers may be eligible for this study. Volunteers may participate in this study if they are 18 - 65 years old. Subjects will participate in two separate 7-hour PET/CT Scan Sessions (each with 2 hours of actual PET/CT scanning): one following an overnight abstinence and one following two overnights of abstinence. To achieve and confirm two overnights of abstinence, participants will present to the inpatient CHPS the day prior to the scheduled scan and stay overnight. The 2-[18F]-FA PET/CT brain scans will consist of an injection followed by an 7-hour infusion of 2-[18F]-FA. The scan session will begin at approximately 4 hours after the bolus injection. The PET/CT scan will occur in two segments. Starting at approximately 4 hours post bolus and infusion start, we will scan for approximately 90 minutes with a bolus injection of IV nicotine that will occur approximately 15 minutes into the scanning procedure. There will be a break in scanning of approximately 60 minutes, during which subjects will be allowed to get off the scanner and use the restroom, if necessary. The second scan segment will start at approximately 6.5 hours post bolus injection, t. This segment will last approximately 30 minutes. The pre and post nicotine images will be analyzed to evaluate for differences in receptor uptake after the nicotine "challenge". Subjects will have a structural Brain MRI performed within 1 year prior to study enrollment or subjects who have not had a Brain MRI that is deemed acceptable for use for this study will undergo a research Brain MRI after consent.

NCT ID: NCT03442231 Active, not recruiting - Clinical trials for Non-inflammatory Degenerative Joint Disease

Journey™ UNI Post Market Clinical Follow-Up

Journey UNI
Start date: April 11, 2018
Phase:
Study type: Observational

This is a retrospective/prospective, open-label single cohort, multicenter study to collect relevant clinical data from 147 subjects with unicompartmental degeneration of the knee in whom the Journey UNI UKS was previously implanted.

NCT ID: NCT03442179 Active, not recruiting - Elderly Clinical Trials

Cognitive Outcomes and Neuroimages Associated With Anesthesia-Related EEG Signatures

Start date: February 13, 2019
Phase:
Study type: Observational

In this study, we propose to evaluate the relationship between the alpha oscillation dynamics and the signals derived from the brain images related to brain aging.

NCT ID: NCT03441971 Active, not recruiting - Clinical trials for Heart Defects, Congenital

Evaluation of the GORE PV1 Device in Patients With Pulmonary Valve Dysfunction

Start date: June 7, 2018
Phase: N/A
Study type: Interventional

This study will assess the safety and performance of the GORE PV1 Device for replacement of the pulmonary valve and reconstruction of the Right Ventricular Outflow Tract (RVOT).

NCT ID: NCT03441867 Active, not recruiting - Epilepsy Clinical Trials

Neuroimaging Biomarker for Seizures

NIBMSZS
Start date: September 15, 2017
Phase: N/A
Study type: Interventional

This multi-site study will examine patients with epilepsy (ES) following head injury [i.e., posttraumatic epilepsy (PTE)] and posttraumatic psychogenic Non-epileptic seizures (PNES) and will compare them to patients with traumatic brain injury (TBI) who do not have seizures using functional neuroimaging.

NCT ID: NCT03441776 Active, not recruiting - Clinical trials for Traumatic Brain Injury

Towards Comparative Effectiveness in Military Vestibular Rehabilitation

Start date: February 9, 2018
Phase: N/A
Study type: Interventional

To prospectively evaluate the tools, environment and resources to compare the effectiveness of two different standard of care vestibular rehabilitation approaches in a military cohort with post-concussive vestibular symptoms.

NCT ID: NCT03441321 Active, not recruiting - Clinical trials for Health Status Unknown

Social-Media Intervention in Reducing Tanning in High-Risk Tanners

Start date: June 1, 2019
Phase: N/A
Study type: Interventional

This randomized clinical trial studies how well social-media intervention works in reducing tanning in high-risk indoor and outdoor tanners. Social-media intervention delivered via Facebook may help to promote healthy behaviors, positive body image, and to understand young women's perception of a social media campaign.